Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Jinhai International Group Holdings Limited ( (HK:2225) ).
Jinhai Medical Technology Limited announced a strategic cooperation framework agreement with Medtronic Changzhou to promote real-time navigation and tracking spinal endoscope techniques in the PRC. This collaboration aims to develop advanced integrated solutions for spinal endoscopy, facilitate academic exchanges, and support clinical demonstrations and training. The agreement, initially set for one year, can be renewed, and formal agreements will be established as conditions mature, potentially enhancing Jinhai’s market position in the medical technology sector.
The most recent analyst rating on (HK:2225) stock is a Hold with a HK$1.00 price target. To see the full list of analyst forecasts on Jinhai International Group Holdings Limited stock, see the HK:2225 Stock Forecast page.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited, incorporated in the Cayman Islands, is an investment holding company with its shares listed on the Main Board of the Stock Exchange. The company, along with its subsidiaries, is involved in providing manpower outsourcing, dormitory services, IT services, construction ancillary services, and minimally invasive surgery solutions and medical products.
Average Trading Volume: 13,974,015
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.98B
See more insights into 2225 stock on TipRanks’ Stock Analysis page.